
GeoVax Labs Investor Relations Material
Latest events

Q2 2025
GeoVax Labs
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from GeoVax Labs Inc
Access all reports
GeoVax Labs Inc is a biotechnology company focused on developing vaccines and immunotherapies for infectious diseases and cancer. The company utilizes its proprietary vaccine platforms to target viral and bacterial pathogens, as well as tumor-associated antigens. Its development pipeline includes both preventive and therapeutic candidates undergoing preclinical and clinical testing. GeoVax Labs Inc is headquartered in Smyrna, Georgia, and its shares are listed on the NASDAQ.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
GOVX
Country
🇺🇸 United States